Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2736-2742
Published online before print September 20, 2007, doi: 10.1161/ATVBAHA.107.154559
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/12/2736    most recent
ATVBAHA.107.154559v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reiner, A. P.
Right arrow Articles by Tracy, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiner, A. P.
Right arrow Articles by Tracy, R. P.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2736.)
© 2007 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

USF1 Gene Variants, Cardiovascular Risk, and Mortality in European Americans

Analysis of Two US Cohort Studies

Alexander P. Reiner; Christopher S. Carlson; Nancy S. Jenny; J. Peter Durda; David S. Siscovick; Deborah A. Nickerson; Russell P. Tracy

From the Departments of Epidemiology (A.P.R., D.S.S.) and Genome Sciences (D.A.N.), University of Washington, Seattle; the Division of Public Health Sciences (C.S.C.), Fred Hutchinson Cancer Research Center, Seattle, Wash; and the Department of Pathology (N.S.J., J.P.D., R.P.T.), University of Vermont College of Medicine, Burlington.

Correspondence to Alex Reiner, Department of Epidemiology, Box 357236, University of Washington, Seattle, WA 98195. E-mail apreiner{at}u.washington.edu

Objective— A common haplotype of the upstream transcription factor 1 gene (USF1) has been associated with decreased susceptibility to familial combined hyperlipidemia (FCHL) and, paradoxically, with increased risk of cardiovascular disease (CVD) and all-cause mortality.

Methods and Results— We assessed associations between USF1 tagSNPs, CVD risk factors, and aging-related phenotypes using data from 2 large population-based cohorts, Coronary Artery Risk Development in Young Adults (CARDIA) and the Cardiovascular Health Study (CHS), comprising younger and older adults, respectively. In CARDIA, each additional copy of the FCHL low-risk allele was associated with 2.4 mg/dL lower levels of LDL cholesterol (P=0.01) and decreased risk of subclinical atherosclerosis as assessed by coronary artery calcium (odds ratio 0.79; 95%CI 0.63 to 0.98). Whereas there was little association between USF1 genotype and metabolic or CVD traits in older adults from CHS, the USF1 low-risk dyslipidemia allele was associated with higher plasma C-reactive protein and interleukin (IL)-6 levels and with increased risk of mortality, particularly attributable to noncardiovascular causes.

Conclusions— There appears to be a complex and possibly age-dependent relationship between USF1 genotype, atherosclerosis phenotypes, and CVD risk. USF1 may influence mortality through pathways distinct from atherosclerosis. Alternatively, linkage disequilibrium with neighboring polymorphisms in other genes such as F11R may be responsible for the observed USF1 genotype–phenotype associations in older adults.

A common haplotype of the gene encoding upstream transcription factor 1 previously associated with decreased susceptibility to familial combined hyperlipidemia is associated with lower cholesterol levels and decreased atherosclerotic risk in young adults, but with increased inflammatory markers and increased mortality in older adults.


Key Words: USF1 • atherosclerosis • CVD • mortality • cholesterol




This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
J. Naukkarinen, E. Nilsson, H. A. Koistinen, S. Soderlund, V. Lyssenko, A. Vaag, P. Poulsen, L. Groop, M.-R. Taskinen, and L. Peltonen
Functional Variant Disrupts Insulin Induction of USF1: Mechanism for USF1-Associated Dyslipidemias
Circ Cardiovasc Genet, October 1, 2009; 2(5): 522 - 529.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. P. Jarvik, J. D. Brunzell, and A. G. Motulsky
Frequent Detection of Familial Hypercholesterolemia Mutations in Familial Combined Hyperlipidemia
J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1554 - 1556.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C Holzapfel, J Baumert, H Grallert, A M Muller, B Thorand, N Khuseyinova, C Herder, C Meisinger, H Hauner, H E Wichmann, et al.
Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Eur. J. Endocrinol., October 1, 2008; 159(4): 407 - 416.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kristiansson, E. Ilveskoski, T. Lehtimaki, L. Peltonen, M. Perola, and P. J. Karhunen
Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 983 - 989.
[Abstract] [Full Text] [PDF]